Connection

Yuki Kageyama to Von Hippel-Lindau Tumor Suppressor Protein

This is a "connection" page, showing publications Yuki Kageyama has written about Von Hippel-Lindau Tumor Suppressor Protein.
  1. Development of a novel interferon-a2b gene construct with a repetitive hypoxia-inducible factor binding site and its suppressive effects on human renal cell carcinoma cell lines in vitro. Int J Clin Oncol. 2014; 19(3):497-504.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.